{
    "organizations": [],
    "uuid": "ac9e2ed801baff05a6065bac2757f532150be223",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-indias-piramal-enterprises-dec-qtr/brief-indias-piramal-enterprises-dec-qtr-consol-profit-up-21-5-pct-idUSFWN1PP07Y",
    "ord_in_thread": 0,
    "title": "BRIEF-India's Piramal Enterprises Dec-Qtr Consol Profit Up 21.5 Pct",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 30 (Reuters) - Piramal Enterprises Ltd:\n* DEC QUARTER CONSOL NET PROFIT 4.91 BILLION RUPEES VERSUS PROFIT OF 4.04 BILLION RUPEES LAST YEAR\n* DEC QUARTER CONSOL REVENUE FROM OPERATIONS 28.58 BILLION RUPEES VERSUS 23.42 BILLION RUPEES LAST YEAR\n* SAYS IN Q3 FY2018, PHARMA SEGMENT REVENUES GREW BY 7 PERCENT TO 10.22 BILLION RUPEES Source text - bit.ly/2nkZhvE Further company coverage:\n ",
    "published": "2018-01-30T15:58:00.000+02:00",
    "crawled": "2018-01-31T16:49:14.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "piramal",
        "enterprise",
        "ltd",
        "dec",
        "quarter",
        "consol",
        "net",
        "profit",
        "billion",
        "rupee",
        "versus",
        "profit",
        "billion",
        "rupee",
        "last",
        "year",
        "dec",
        "quarter",
        "consol",
        "revenue",
        "operation",
        "billion",
        "rupee",
        "versus",
        "billion",
        "rupee",
        "last",
        "year",
        "say",
        "q3",
        "fy2018",
        "pharma",
        "segment",
        "revenue",
        "grew",
        "percent",
        "billion",
        "rupee",
        "source",
        "text",
        "company",
        "coverage"
    ]
}